Cincinnati, OH, United States of America

Cara Geary


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal1 out of 832,891 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Cara Geary

Introduction

Cara Geary is an accomplished inventor based in Cincinnati, OH (US). She has made significant contributions to the field of medical science, particularly in the treatment of ciliary dyskinesia. Her innovative approach aims to enhance mucociliary clearance, which is crucial for respiratory health.

Latest Patents

Cara Geary holds a patent for a method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues. This invention is directed towards stimulating ciliary beat frequency to promote mucociliary or cough clearance of retained mucus secretions from various parts of the body, including the lungs, sinuses, and upper airways. The method involves administering uridine triphosphates, adenosine triphosphates, cytidine triphosphates, or dinucleoside tetraphosphates and their derivatives to treat dysfunction in the mucociliary clearance system.

Career Highlights

Throughout her career, Cara has demonstrated a commitment to advancing medical treatments through her innovative research. Her work has the potential to significantly improve the quality of life for patients suffering from impaired ciliary movement.

Collaborations

Cara has collaborated with notable professionals in her field, including Karla M Jacobus and Benjamin R Yerxa. These partnerships have contributed to the development and refinement of her innovative methods.

Conclusion

Cara Geary's contributions to the field of medical science through her patent on treating ciliary dyskinesia exemplify her dedication to innovation. Her work not only showcases her inventive spirit but also holds promise for improving patient care in respiratory health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…